Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Mol Genet Genomics ; 265(6): 1120-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11523785

ABSTRACT

We show that co-expression of rat Galphas together with type I, II, IV, or VI mammalian adenylyl cyclase (AC) can suppress the growth defect of cyr1 strains of Saccharomyces cerevisiae, which lack a functional endogenous AC. Complemention of cvr1 is not observed in the absence of Galphas, indicating that the mammalian ACs retain their normal regulatory behavior in yeast. Selection for Galphas-independent growth of (cyr1 strains expressing type IV AC yielded several ACIV mutants with enhanced basal activity, each of which had a single amino acid substitution in the conserved C1a or C2a region of the protein. Expression of two of the mutant ACs in HEK293 cells resulted in increased levels of cAMP and elevated adenylyl cyclase activity. Further selection for reverting mutations in one of these constitutively active AC mutants yielded three independent intragenic suppressor mutations. The distribution of the activating and suppressor mutations throughout both C1a and C2a is consistent with a model in which the enhanced basal activity results from an increase in the affinity between C1a and C2a. These results demonstrate the utility of Saccharomyces as a tool for the identification of informative mutant forms of mammalian ACs.


Subject(s)
Adenylyl Cyclases/genetics , Adenylyl Cyclases/metabolism , Saccharomyces cerevisiae/genetics , Adenylyl Cyclases/chemistry , Amino Acid Sequence , Animals , Cell Line , Genes, Reporter , Genetic Complementation Test , Guanosine Triphosphate/metabolism , Heterotrimeric GTP-Binding Proteins/genetics , Heterotrimeric GTP-Binding Proteins/metabolism , Humans , Isoenzymes/genetics , Isoenzymes/metabolism , Mammals , Models, Molecular , Molecular Sequence Data , Protein Conformation , Rats , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/growth & development , Sequence Homology, Amino Acid , Transfection , beta-Galactosidase/genetics , beta-Galactosidase/metabolism
2.
Life Sci ; 68(19-20): 2301-8, 2001 Apr 06.
Article in English | MEDLINE | ID: mdl-11358340

ABSTRACT

Heterotrimeric G-protein signalling systems are primarily activated via cell surface receptors possessing the seven membrane span motif. Several observations suggest the existence of other modes of input to such signalling systems either downstream of effectors or at the level of G-proteins themselves. Using a functional screen based upon the pheromone response pathway in Saccharomyces cerevisiae, we identified three proteins, AGS1-3 (for Activators of G-protein Signalling), that activated heterotrimeric G-protein signalling pathways in the absence of a typical receptor. AGS1 defines a distinct member of the super family of ras related proteins. AGS2 is identical to mouse Tctex1, a protein that exists as a light chain component of the cytoplasmic motor protein dynein and subserves as yet undefined functions in cell signalling pathways. AGS3 possesses a series of tetratrico repeat motifs and a series of four amino acid repeats termed G-protein regulatory motifs. The GPR motifs are found in a number of proteins that interact with and regulate Galpha. Although each AGS protein activates G-protein signaling, they do so by different mechanisms within the context of the G-protein activation/deactivation cycle. AGS proteins provide unexpected mechanisms for input to heterotrimeric G-protein signalling pathways.


Subject(s)
Chemoreceptor Cells/metabolism , Heterotrimeric GTP-Binding Proteins/metabolism , Receptors, Cell Surface/metabolism , Signal Transduction , Animals , GTP-Binding Proteins/genetics , GTP-Binding Proteins/metabolism , Humans , Mice , Molecular Sequence Data , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , ras Proteins/genetics , ras Proteins/metabolism
3.
Endocrinology ; 142(5): 1935-49, 2001 May.
Article in English | MEDLINE | ID: mdl-11316759

ABSTRACT

Mechanisms of transcriptional regulation of the human beta(3)-adrenergic receptor were studied using SK-N-MC cells, a human neuroblastoma cell line that expresses beta(3)- and beta(1)-adrenergic receptors endogenously. Deletions spanning different portions of a 7-kb 5'-flanking region of the human beta(3)-adrenergic receptor gene were linked to a luciferase reporter and transfected in SK-N-MC, CV-1, and HeLa cells. Maximal luciferase activity was observed when a 200-bp region located between -6.5 and -6.3 kb from the translation start site was present. This region functioned only in SK-N-MC cells. Electrophoretic mobility shift assays of nuclear extracts from SK-N-MC, CV-1, and HeLa cells using double stranded oligonucleotides spanning different portions of the 200-bp region as probes and transient transfection studies revealed the existence of three cis-acting regulatory elements: A) -6.468 kb-AGGTGGACT--6.458 kb, B) -6.448 kb-GCCTCTCTGGGGAGCAGCTTCTCC-6.428 kb, and C) -6.405 kb-20 repeats of CCTT-6.385 kb. These elements act together to achieve full transcriptional activity. Mutational analysis, antibody supershift, and electrophoretic mobility shift assay competition experiments indicated that element A binds the transcription factor Sp1, element B binds protein(s) present only in nuclear extracts from SK-N-MC cells and brown adipose tissue, and element C binds protein(s) present in both SK-N-MC and HeLa cells. In addition, element C exhibits characteristics of an S1 nuclease-hypersensitive site. These data indicate that cell-specific positive cis-regulatory elements located 6.5 kb upstream from the translation start site may play an important role in transcriptional regulation of the human beta(3)-adrenergic receptor. These data also suggest that brown adipose tissue-specific transcription factor(s) may be involved in the tissue-specific expression of the beta(3)-adrenergic receptor gene.


Subject(s)
Enhancer Elements, Genetic , Gene Expression Regulation , Receptors, Adrenergic, beta-3/genetics , Adipose Tissue, Brown/metabolism , Base Sequence , Binding Sites , Genes, Regulator , Humans , Molecular Sequence Data , Neuroblastoma/genetics , Promoter Regions, Genetic , Single-Strand Specific DNA and RNA Endonucleases/metabolism , Sp1 Transcription Factor/metabolism , Transcription, Genetic , Tumor Cells, Cultured
4.
J Biol Chem ; 275(31): 23421-4, 2000 Aug 04.
Article in English | MEDLINE | ID: mdl-10840027

ABSTRACT

Utilizing a functional screen in the yeast Saccharomyces cerevisiae we identified mammalian proteins that activate heterotrimeric G-protein signaling pathways in a receptor-independent fashion. One of the identified activators, termed AGS1 (for activator of G-protein signaling), is a human Ras-related G-protein that defines a distinct subgroup of the Ras superfamily. Expression of AGS1 in yeast and in mammalian cells results in specific activation of Galpha(i)/Galpha(o) heterotrimeric signaling pathways. In addition, the in vivo and in vitro properties of AGS1 are consistent with it functioning as a direct guanine nucleotide exchange factor for Galpha(i)/Galpha(o). AGS1 thus presents a unique mechanism for signal integration via heterotrimeric G-protein signaling pathways.


Subject(s)
GTP-Binding Protein alpha Subunits, Gi-Go , GTP-Binding Proteins/metabolism , Guanine Nucleotide Exchange Factors/metabolism , Heterotrimeric GTP-Binding Proteins/metabolism , Proto-Oncogene Proteins/metabolism , ras Proteins/metabolism , Amino Acid Sequence , DNA, Complementary , GTP-Binding Protein alpha Subunit, Gi2 , GTP-Binding Protein alpha Subunits , GTP-Binding Proteins/genetics , Guanosine Triphosphate/metabolism , Heterotrimeric GTP-Binding Proteins/genetics , Humans , Hydrolysis , Molecular Sequence Data , Protein Binding , Proto-Oncogene Proteins/genetics , Saccharomyces cerevisiae , Sequence Homology, Amino Acid , Signal Transduction , ras Proteins/genetics
5.
J Biol Chem ; 275(15): 10767-71, 2000 Apr 14.
Article in English | MEDLINE | ID: mdl-10753868

ABSTRACT

Uridine 5'-diphosphoglucose (UDP-glucose) has a well established biochemical role as a glycosyl donor in the enzymatic biosynthesis of carbohydrates. It is less well known that UDP-glucose may possess pharmacological activity, suggesting that a receptor for this molecule may exist. Here, we show that UDP-glucose, and some closely related molecules, potently activate the orphan G protein-coupled receptor KIAA0001 heterologously expressed in yeast or mammalian cells. Nucleotides known to activate P2Y receptors were inactive, indicating the distinctly novel pharmacology of this receptor. The receptor is expressed in a wide variety of human tissues, including many regions of the brain. These data suggest that some sugar-nucleotides may serve important physiological roles as extracellular signaling molecules in addition to their familiar role in intermediary metabolism.


Subject(s)
GTP-Binding Proteins/physiology , Receptors, Cell Surface/physiology , Uridine Diphosphate Glucose/physiology , Humans , Phylogeny , Radioligand Assay , Receptors, Cell Surface/analysis
6.
J Biol Chem ; 274(47): 33202-5, 1999 Nov 19.
Article in English | MEDLINE | ID: mdl-10559191

ABSTRACT

Heterotrimeric G-protein signaling systems are activated via cell surface receptors possessing the seven-membrane span motif. Several observations suggest the existence of other modes of stimulus input to heterotrimeric G-proteins. As part of an overall effort to identify such proteins we developed a functional screen based upon the pheromone response pathway in Saccharomyces cerevisiae. We identified two mammalian proteins, AGS2 and AGS3 (activators of G-protein signaling), that activated the pheromone response pathway at the level of heterotrimeric G-proteins in the absence of a typical receptor. beta-galactosidase reporter assays in yeast strains expressing different Galpha subunits (Gpa1, G(s)alpha, G(i)alpha(2(Gpa1(1-41))), G(i)alpha(3(Gpa1(1-41))), Galpha(16(Gpa1(1-41)))) indicated that AGS proteins selectively activated G-protein heterotrimers. AGS3 was only active in the G(i)alpha(2) and G(i)alpha(3) genetic backgrounds, whereas AGS2 was active in each of the genetic backgrounds except Gpa1. In protein interaction studies, AGS2 selectively associated with Gbetagamma, whereas AGS3 bound Galpha and exhibited a preference for GalphaGDP versus GalphaGTPgammaS. Subsequent studies indicated that the mechanisms of G-protein activation by AGS2 and AGS3 were distinct from that of a typical G-protein-coupled receptor. AGS proteins provide unexpected mechanisms for input to heterotrimeric G-protein signaling pathways. AGS2 and AGS3 may also serve as novel binding partners for Galpha and Gbetagamma that allow the subunits to subserve functions that do not require initial heterotrimer formation.


Subject(s)
Heterotrimeric GTP-Binding Proteins/metabolism , Signal Transduction , Amino Acid Sequence , Animals , Base Sequence , DNA Primers , Molecular Sequence Data , Rats , Saccharomyces cerevisiae/genetics , Sequence Homology, Amino Acid
7.
Nat Biotechnol ; 17(9): 878-83, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10471929

ABSTRACT

We describe genetic screens in Saccharomyces cerevisiae designed to identify mammalian nonreceptor modulators of G-protein signaling pathways. Strains lacking a pheromone-responsive G-protein coupled receptor and expressing a mammalian-yeast Galpha hybrid protein were made conditional for growth upon either pheromone pathway activation (activator screen) or pheromone pathway inactivation (inhibitor screen). Mammalian cDNAs that conferred plasmid-dependent growth under restrictive conditions were identified. One of the cDNAs identified from the activator screen, a human Ras-related G protein that we term AGS1 (for activator of G-protein signaling), appears to function by facilitating guanosine triphosphate (GTP) exchange on the heterotrimeric Galpha. A cDNA product identified from the inhibitor screen encodes a previously identified regulator of G-protein signaling, human RGS5.


Subject(s)
Cloning, Molecular/methods , GTP-Binding Proteins/isolation & purification , GTP-Binding Proteins/metabolism , Saccharomyces cerevisiae/genetics , Signal Transduction/genetics , ras Proteins/isolation & purification , DNA, Complementary/genetics , Epistasis, Genetic , GTP-Binding Proteins/genetics , Gene Library , Genetic Engineering , Humans , Phenotype , Pheromones/metabolism , Protein Binding , Saccharomyces cerevisiae/cytology , Selection, Genetic , Transformation, Genetic , ras Proteins/genetics
8.
Bioorg Med Chem Lett ; 9(16): 2413-8, 1999 Aug 16.
Article in English | MEDLINE | ID: mdl-10476879

ABSTRACT

Evaluation of a biased "library" of pyrrolo[2,3-d]pyrimidines using yeast-based functional assays expressing human A1- and A2a-adenosine receptors, led to the A1 selective antagonist 4b. A direct correlation between yeast functional activity and binding data was established. Practical compounds with polar residues at C-4 of the pyrrolopyrimidine system required H-bond donor functionality for high potency.


Subject(s)
Purinergic P1 Receptor Antagonists , Pyrimidines/pharmacology , Saccharomyces cerevisiae/genetics , Binding, Competitive , Cell Line , Humans , Hydrogen Bonding , Pyrimidines/chemistry , Pyrimidines/metabolism , Radioligand Assay , Receptors, Purinergic P1/genetics , Receptors, Purinergic P1/metabolism , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
9.
J Biol Chem ; 273(5): 3097-104, 1998 Jan 30.
Article in English | MEDLINE | ID: mdl-9446627

ABSTRACT

Substance P derivatives are potential therapeutic compounds for the treatment of small cell lung cancer and can cause apoptosis in small cell lung cancer cells in culture. These peptides act as broad spectrum neuropeptide antagonists, blocking calcium mobilization induced by gastrin-releasing peptide, bradykinin, cholecystokinin, and other neuropeptides. We show that [D-Arg1,D-Phe5,D-Trp7,9, Leu11]substance P has unique agonist activities in addition to this described antagonist function. At doses that block calcium mobilization by neuropeptides, this peptide causes activation of c-Jun N-terminal kinase and cytoskeletal changes in Swiss 3T3 fibroblasts and stimulates migration and calcium flux in human neutrophils. Activation of c-Jun N-terminal kinase is dependent on the expression of the gastrin-releasing peptide receptor in rat 1A fibroblasts, demonstrating that the responses to the peptide are receptor-mediated. We hypothesize that [D-Arg1,D-Phe5,D-Trp7,9, Leu11]substance P acts as a biased agonist on neuropeptide and related receptors, activating certain guanine nucleotide-binding proteins through the receptor, but not others.


Subject(s)
Mitogen-Activated Protein Kinases , Receptors, Chemokine/agonists , Receptors, Neuropeptide/agonists , Signal Transduction/drug effects , Substance P/analogs & derivatives , Substance P/pharmacology , 3T3 Cells , Animals , Antigens, CD/drug effects , Calcium/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Humans , JNK Mitogen-Activated Protein Kinases , Mice , Neutrophils/metabolism , Rats , Receptors, Bombesin/metabolism , Receptors, Interleukin/drug effects , Receptors, Interleukin-8A
10.
Pflugers Arch ; 435(2): 280-5, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9382943

ABSTRACT

The ability of recombinant rat alpha2D-and alpha2B-adrenoceptors expressed in nerve-growth-factor-differentiated pheochromocytoma PC-12 cells to modulate Ca2+ currents, recorded by the whole-cell patch-clamp technique, has been studied. Ca2+ currents in different cells were either reversibly reduced or increased by dexmedetomidine, an alpha2-adrenergic agonist, in a concentration-dependent manner. Pertussis toxin pretreatment reduced the number of cells that showed an inhibitory response and reduced the magnitude of inhibition. In cells expressing the alpha2B-adrenoceptor, pertussis toxin increased the proportion of cells from which a stimulatory effect on Ca2+ currents could be recorded. The magnitude of the inhibitory responses was unaffected but the stimulatory responses were considerably reduced by the dihydropyridine Ca2+ channel blocker nifedipine (5 microM). All effects of dexmedetomidine were reversible upon wash-out and inhibited by the antagonist rauwolscine. The results support the idea that modulation of voltage-dependent Ca2+ channels in transfected PC-12 cells is mediated by activation of recombinant alpha2D- and alpha2B-adrenoceptors. This receptor activation predominantly causes inhibition of dihydropyridine-insensitive Ca2+ channels via pertussis-toxin-sensitive G proteins. Additionally receptor activation can also lead to stimulation of dihydropyridine-sensitive Ca2+ channels via pertussis-toxin-insensitive mechanisms.


Subject(s)
Calcium Channels/physiology , Neurons/physiology , Receptors, Adrenergic, alpha/physiology , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Cyclic AMP/pharmacology , Electric Conductivity , GTP-Binding Proteins/physiology , Imidazoles/pharmacology , Medetomidine , Nifedipine/pharmacology , PC12 Cells , Patch-Clamp Techniques , Pertussis Toxin , Rats , Recombinant Proteins , Transfection , Virulence Factors, Bordetella/pharmacology , Yohimbine/pharmacology
11.
Am J Physiol ; 273(2 Pt 2): H971-80, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9277517

ABSTRACT

The influence of arginine vasopressin (AVP) on agonist-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) accumulation was investigated in vascular smooth muscle cells (VSMC) cultured from rat thoracic aorta. Incubation of VSMC with AVP for 60 s produced a 2- to 2.5-fold enhancement of isoproterenol-induced cAMP formation. AVP also increased cAMP stimulation by the prostaglandin I2 analogue iloprost. The effect of AVP to enhance agonist-stimulated cAMP formation was completely inhibited in cells pretreated with a selective antagonist of V1 vasopressin receptors but was not affected by blockade of V2 receptors. Inhibition of protein kinase C activation failed to alter the action of AVP to potentiate cAMP stimulation, but treatment of cells with calmodulin antagonists significantly attenuated this effect of the peptide. Moreover, depletion of Ca2+ stores with thapsigargin decreased AVP enhancement of isoproterenol-stimulated cAMP by > 70%. The action of AVP to increase cAMP stimulation was also demonstrated in freshly isolated strips of rat aorta where treatment with peptide produced a twofold increase in isoproterenol-stimulated cAMP formation. RNA blot analysis indicated expression in VSMC of mRNA encoding type III adenylyl cyclase, a Ca(2+)-calmodulin-sensitive isoform of the effector. Furthermore, when detergent-solubilized membrane extract was subjected to calmodulin affinity chromatography, a peak of adenylyl cyclase activity was identified which had affinity for calmodulin matrix in the presence of Ca2+. The results indicate that AVP activates V1 receptors in VSMC to enhance agonist-stimulated cAMP formation by a Ca(2+)-calmodulin-dependent mechanism and suggest that type III adenylyl cyclase may provide a focal point in the VSMC for cross talk between constrictor and dilator pathways.


Subject(s)
Adenylyl Cyclases/metabolism , Arginine Vasopressin/pharmacology , Cyclic AMP/agonists , Cyclic AMP/metabolism , Isoenzymes/metabolism , Muscle, Smooth, Vascular/metabolism , Angiotensin II/pharmacology , Animals , Antidiuretic Hormone Receptor Antagonists , Aorta/cytology , Aorta/drug effects , Aorta/metabolism , Calcium/physiology , Calmodulin/physiology , Cells, Cultured , In Vitro Techniques , Isoproterenol/pharmacology , Male , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Protein Kinase C/physiology , Rats , Rats, Sprague-Dawley
12.
J Biol Chem ; 272(24): 15466-73, 1997 Jun 13.
Article in English | MEDLINE | ID: mdl-9182579

ABSTRACT

We report that two subtypes of alpha2-adrenergic receptors (alpha2A/D- and alpha2C-AR) are ectopically expressed with dramatically different efficiencies and that this difference is due to a 288-nucleotide (nt) segment in the 3'-untranslated region (3'-UTR) of the alpha2C-AR mRNA that impairs translational processing. NIH-3T3 fibroblasts were transfected with receptor constructs (coding region plus 552 nt, alpha2C-AR; coding region plus 1140 nt, alpha2A/D-AR) and a vector conferring G418 resistance. Transcription was driven by the murine sarcoma virus promoter element, and the receptor gene segment was upstream of an SV40 polyadenylation cassette. Drug-resistant transfectants were evaluated for expression of receptor mRNA and protein. 90% of the NIH-3T3 alpha2C-AR transfectants expressed receptor mRNA, but only 14% of the clonal cell lines expressed receptor protein. In contrast, 90% of the NIH-3T3 alpha2A/D-AR transfectants expressed receptor protein (200-5000 fmol/mg). Similar results were obtained following transfection of DDT1MF-2 cells with the two receptor constructs. The role of the 3'-UTR of the alpha2C-AR in mRNA processing was determined by generating new constructs in which the 3'-UTR was progressively truncated from 552 to 470, 182, 143, or 74 nt 3' to the stop codon. Truncation of the 3'-UTR resulted in the expression of receptor protein in the G418-resistant transfectants (nt 74, 100%; nt 143, 80%; nt 182, 50%). The level of mRNA in the transfectants expressing the receptor protein was not greater than that in nonexpressing clones, and the differences in protein expression did not reflect altered mRNA stability in the truncated construct. The alpha2C-AR mRNA with the longer 3'-UTR underwent translational initiation as it was found in the polysome fraction, indicating that the lack of receptor protein was due to impaired translational elongation or termination. These data suggest that translational efficiency is a key mechanism for regulating alpha2C-AR expression and associated signaling events.


Subject(s)
Protein Biosynthesis , RNA, Messenger/genetics , Receptors, Adrenergic, alpha-2/genetics , 3T3 Cells , Animals , Base Sequence , Cell Line , DNA , Mice , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Messenger/chemistry
13.
FEBS Lett ; 384(3): 273-6, 1996 Apr 22.
Article in English | MEDLINE | ID: mdl-8617370

ABSTRACT

Abstract Type V adenylyl cyclase (AC) was stably over-expressed in HEK293 cells (293AC-V). Forskolin-stimulated cAMP accumulation in 293AC-V was 5 times as great as that in control cells. PMA, a protein kinase C (PKC) activator, enhanced cAMP accumulation in 293AC-V cells dose-and time-dependently and this enhancement was abolished by staurosporine. Insulin also enhanced cAMP accumulation in 293AC-V cells. Co-transfection of PKC-zeta, but not PKC-alpha, potentiated the effects of insulin. These data suggest that type V AC activity is regulated in cells by PKC isoenzymes through different extracellular stimuli.


Subject(s)
Adenylyl Cyclases/metabolism , Isoenzymes/metabolism , Kidney/cytology , Protein Kinase C/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Adenylyl Cyclases/genetics , Alkaloids/pharmacology , Cells, Cultured , Cyclic AMP/biosynthesis , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Humans , Insulin/pharmacology , Kidney/embryology , Molecular Sequence Data , Protein Kinase C/antagonists & inhibitors , Staurosporine , Time Factors , Transfection
14.
Pharmacology ; 52(4): 252-62, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8841088

ABSTRACT

The receptor-coupling efficiency for epinephrine (EPI) stimulated heterotrimeric G protein activation was studied at the G protein level in membranes prepared from PC12 cells expressing cloned alpha 2D-adrenergic receptors (alpha 2D-AR). After pretreatment with different concentrations of N-ethoxycarbonyl-1,2-dihydroquinoline, which irreversibly inactivates alpha 2D-AR, the portion of alpha 2D-ARs remaining active (q) was estimated from EPI-stimulated [35S]GTP gamma S binding. This function-derived estimate was close to the actual remaining number of receptors, as determined in saturation-binding studies using the selective alpha 2-AR antagonist [3H]rauwolscine in the same membranes. The agonist dissociation constant (KA) derived from EPI-stimulated [35S]GTP gamma S binding via Furchgott analysis was similar to the EC50 of EPI in the same assay, but 40-fold lower than its Ki measured from EPI competition for [3H]rauwolscine-binding sites in the presence of GTP gamma S and Na+. The occupancy-response relationship, calculated using Ki rather than KA, was markedly nonlinear, consistent with the high expression of alpha 2D-AR in these membranes. A nonlinear occupancy-response relationship was more directly confirmed by measuring the maximal level (i.e., full occupancy level) of G protein activation at graded densities of alpha AD-AR after N-ethoxycarbonyl-1,2-dihydroquinoline treatment. Determination of the number of G-proteins activated per receptor yielded lower values at higher receptor densities, indicating that overexpression of receptors can reduce their efficiency. Our results indicate the potential utility of using GTP-binding studies to assess agonist efficacy at the G protein level under conditions where receptor occupation can also be directly measured.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Epinephrine/pharmacology , GTP-Binding Proteins/metabolism , Receptors, Adrenergic, alpha-2/drug effects , Signal Transduction , Animals , Enzyme Activation , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , PC12 Cells , Quinolines/pharmacology , Rats , Receptors, Adrenergic, alpha-2/metabolism
15.
Am J Physiol ; 269(1 Pt 1): E162-71, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7631772

ABSTRACT

Activation of alpha 2-adrenergic receptors (alpha 2-AR) in pancreatic beta-cells inhibits insulin secretion in response to various stimuli, and acute or long-term regulation of alpha 2-AR receptor-mediated effects may influence the tissue response to glucose dishomeostasis. As an initial approach to this issue, we determined the effect of various metabolic and hormonal treatments on alpha 2-AR expression and coupling in the pancreatic beta-cell lines HIT-T15 and RIN-5AH. Radioligand binding studies ([3H]RX-821002) and RNA blot analysis indicate that both pancreatic beta-cell lines express the alpha 2A/D-AR subtype [for HIT-T15 the maximum binding (Bmax) = 113 +/- 28; for RIN-5AH Bmax = 93 +/- 18 fmol/mg of cellular protein]. Treatment of HIT-T15 or RIN-5AH cells with glucocorticoids [dexamethasone, hydrocortisone, or prednisolone (1 microM)] increased alpha 2-AR mRNA level and receptor protein density three- to fivefold. The glucocorticoid-induced increase in receptor density in HIT-T15 cells was associated with 1) an increase in the amount of receptors coupled to G protein as determined by analysis of high-affinity 5'-guanylyl imidodiphosphate-sensitive binding of [3H]UK-14304, a selective alpha 2-AR agonist, and 2) a greater inhibition of forskolin-induced elevation of cellular adenosine 3',5'-cyclic monophosphate after receptor activation. Receptor density in HIT-T15 cells was not altered by different growth conditions, insulin (1 microM), phorbol 12-myristate 13-acetate (1 microM), or the sex steroids testosterone and progesterone (1 microM). These data indicate that glucocorticoids upregulate alpha 2-AR expression and signaling in pancreatic beta-cells. Such regulation may operate in a cell-specific manner, allowing discrete modulation of tissue responses to glucose dishomeostasis.


Subject(s)
Islets of Langerhans/physiology , Receptors, Adrenergic, alpha/metabolism , Signal Transduction , Animals , Cell Line , Cricetinae , Dexamethasone/pharmacology , Mesocricetus , Rats , Up-Regulation
16.
Mol Pharmacol ; 45(3): 524-31, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8145737

ABSTRACT

The ability of agonist-occupied alpha 2D-adrenergic receptors to activate G proteins was measured in membranes from PC-12 cells stably expressing the cloned receptor, using guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTP gamma S) binding as an endpoint. Epinephrine (EPI) stimulated [35S]GTP gamma S binding in a Mg(2+)-dependent manner, showing both micromolar and millimolar cation affinities. Prior treatment of cells with pertussis toxin completely eliminated the EPI stimulation. The presence of GDP decreased basal [35S]GTP gamma S binding and increased the proportion of EPI-stimulated binding. Increasing concentrations of Na+ also reduced basal [35S]GTP gamma S binding but had less effect on EPI-stimulated binding, such that the agonist response was proportionately greater at higher Na+ levels. In saturation binding studies with [35S]GTP gamma S only low affinity binding was observed in the presence of 100 mM Na+, whereas in the absence of Na+ a high affinity component was also present, indicating a Na(+)-regulated receptor/G protein interaction. EPI induced high affinity [35S]GTP gamma S binding in the presence of Na+ and increased the affinity of the high affinity component under Na(+)-free conditions. The selective alpha 2-adrenergic antagonist rauwolscine produced rightward shifts of EPI dose-response curves and decreased the basal level of [35-S]GTP gamma S binding across the same range of concentrations. The extent of decrease was dependent upon the alpha 2-adrenergic receptor expression level, indicating that alpha 2-adrenergic receptors contribute to basal G protein activation in the absence of agonist. The ability of rauwolscine to decrease basal [35S]GTP gamma S binding was diminished as the level of Na+ was increased, suggesting that both agents act to reduce receptor/G protein interaction, by distinctive mechanisms. alpha 2-Adrenergic receptor antagonists reduced basal G protein activation with a rank order for maximal effectiveness that was different from their receptor binding affinities. These results support the existence of precoupling between alpha 2D-adrenergic receptors and G proteins; coupling can be diminished by both Na+ and antagonists, whereas agonists increase the efficiency of receptor/G protein coupling.


Subject(s)
GTP-Binding Proteins/metabolism , Receptors, Adrenergic, alpha-2/metabolism , Animals , Binding Sites , Cell Membrane/metabolism , Epinephrine/metabolism , Epinephrine/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , PC12 Cells , Rats , Receptors, Adrenergic, alpha-2/drug effects , Yohimbine/metabolism , Yohimbine/pharmacology
17.
Am J Physiol ; 265(6 Pt 1): E928-34, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8279549

ABSTRACT

Thromboxane A2 (TxA2), a platelet aggregator and vasoconstrictor, has been implicated as a potential mediator of cardiovascular diseases. Abuse of androgenic steroids has been associated with thrombotic cardiovascular diseases. Human erythroleukemia (HEL) cells, a megakaryocyte-like cell line, express functional TxA2/prostaglandin H2 (PGH2) receptors with characteristics similar to those seen in platelets. This study characterized testosterone regulation of HEL cell TxA2/PGH2 receptors. TxA2/PGH2 receptor affinity (Kd) and density (Bmax) were determined via equilibrium binding experiments using the radiolabeled TxA2 mimetic (1S-[1 alpha,2 beta(5Z),3 alpha(1E,3R*),4 alpha])-7-(3-[3-hydroxy-4-(4'- iodophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]heptan-2-yl)-5-he ptenoic acid (125I-labeled BOP). Testosterone (200 nM) but not estradiol increased Bmax from 108 +/- 9 fmol/mg protein to 157 +/- 9 fmol/mg protein (n = 7 experiments; P < 0.01) without any significant change in Kd. Testosterone had no significant effect on alpha 2-adrenergic receptor density. The maximum increase in intracellular free calcium induced by the TxA2 agonists I-BOP or U-46619 was significantly (P < 0.005) greater in testosterone-treated cells compared with controls. Hydroxyflutamide (1 microM), an androgen-receptor antagonist, completely blocked the effect of testosterone (P < 0.01). Dihydrotestosterone, the active metabolite of testosterone, also increased Bmax in a concentration-dependent manner and was more potent than testosterone. The effect of testosterone to increase Bmax was significantly (P < 0.01) inhibited by coincubation with cycloheximide (0.1 microgram/ml) or actinomycin D (10 ng/ml). These results indicate that androgenic steroids regulate the expression of functional TxA2/PGH2 receptors in HEL cells. These findings may have relevance to cardiovascular disease.


Subject(s)
Dihydrotestosterone/pharmacology , Estradiol/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Receptors, Prostaglandin/biosynthesis , Receptors, Thromboxane/biosynthesis , Testosterone/pharmacology , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid , 5-alpha Reductase Inhibitors , Azasteroids/pharmacology , Calcium/metabolism , Cell Line , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Dihydrotestosterone/analogs & derivatives , Humans , Kinetics , Leukemia, Erythroblastic, Acute , Prostaglandin Endoperoxides, Synthetic/pharmacology , Prostaglandin H2 , Prostaglandins H/metabolism , Receptors, Thromboxane A2, Prostaglandin H2 , Thromboxane A2/analogs & derivatives , Thromboxane A2/pharmacology , Tumor Cells, Cultured , Vasoconstrictor Agents/pharmacology
18.
J Biol Chem ; 267(33): 24045-52, 1992 Nov 25.
Article in English | MEDLINE | ID: mdl-1358886

ABSTRACT

A number of diverse signaling pathways can be activated by G-protein coupled receptors. However, the factors involved in selection of a particular transduction pathway by a single receptor are not well understood. We are attempting to address this issue utilizing the alpha 2-adrenergic receptor (alpha 2-AR) subfamily as a representative model system. In this report, we demonstrate that the cellular response mediated by an alpha 2-AR subtype is cell-specific and thus depends on its environment. Receptor coupling to adenylylcyclase was determined following stable expression of the rat alpha 2B- and alpha 2D-AR subtypes in three functionally distinct cell types (NIH-3T3 fibroblasts, DDT1 MF-2 smooth muscle cells, and the pheochromocytoma cell line PC-12). When the receptor subtype gene is expressed in NIH-3T3 and DDT1 MF-2 cells, receptor activation inhibits basal and forskolin-induced increases in cellular cAMP. However, in PC-12 transfectants the same receptor subtype actually increases basal cAMP and augments the effect of forskolin. Potentiation of the forskolin effect in PC-12 cells is insensitive to pertussis toxin but is blocked by loading the cells with BAPTA (bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid) which minimizes changes in Ca2+i by calcium chelation. These data and the functional demonstration of a Ca2+/calmodulin-sensitive adenylylcyclase in PC-12 but not NIH-3T3 and DDT1 MF-2 cells, suggests that the cell-specific effects of epinephrine are due to receptor coupling to both different G-proteins and types of adenylylcyclase.


Subject(s)
Calcium/metabolism , GTP-Binding Proteins/metabolism , Receptors, Adrenergic, beta/metabolism , Signal Transduction/physiology , 3T3 Cells , Adrenergic alpha-Agonists/pharmacology , Animals , Brimonidine Tartrate , Cell Line , Colforsin/pharmacology , Cyclic AMP/metabolism , Edetic Acid/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Epinephrine/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Kinetics , Manganese/pharmacology , Mice , Muscle, Smooth/metabolism , PC12 Cells , Pertussis Toxin , Quinoxalines/pharmacology , Rats , Receptors, Adrenergic, beta/classification , Receptors, Adrenergic, beta/genetics , Transfection , Virulence Factors, Bordetella/pharmacology
19.
J Biol Chem ; 267(14): 9844-51, 1992 May 15.
Article in English | MEDLINE | ID: mdl-1349606

ABSTRACT

alpha 2-Adrenergic receptor (alpha 2-AR) subtypes couple to pertussis toxin (PT)-sensitive G-proteins to elicit both stimulatory and inhibitory cell responses. Signal specificity may be generated by the ability of the receptor subtypes to "recognize" distinct G-proteins with different affinity. To address this issue we stably expressed three alpha 2-AR subtypes, RNG alpha 2 (alpha 2B-AR), RG10 (alpha 2C-AR), and RG20 (alpha 2D-AR), in NIH-3T3 fibroblasts, which express two PT-sensitive G-proteins (Gi alpha 2, Gi alpha 3), and analyzed receptor/G-protein interactions by determining: 1) functional coupling to adenylylcyclase and 2) the ability of the receptors to exist in a high affinity state for agonist. In alpha 2D-AR transfectants expressing 200 or 2,200 fmol of receptor/mg of protein, epinephrine (10 microM) inhibited forskolin-induced elevation of cellular cAMP by 26 +/- 4.8% and 72 +/- 6.2%, respectively. Similar results were obtained in alpha 2B-AR transfectants. However, in alpha 2C-AR transfectants (200 fmol/mg) the forskolin-induced elevation of cellular cAMP was not altered by agonist treatment. In alpha 2C-AR transfectants expressing higher receptor densities (650-1,200 fmol/mg), epinephrine inhibited the effect of forskolin by 30 +/- 3.2%. This difference in functional coupling among the alpha 2-AR subtypes is reflected at the receptor/G-protein interface. In membrane preparations of alpha 2B and alpha 2D-AR but not alpha 2C-AR transfectants, agonist competition curves were biphasic, indicating high and low affinity states of the receptor for agonist. The high affinity state was guanyl-5'-yl imidodiphosphate- and PT-sensitive, indicative of receptor/G-protein coupling. These data suggest that the alpha 2C-AR differs from the alpha 2B and alpha 2D-AR subtypes in its ability to recognize PT-sensitive G-proteins expressed in NIH-3T3 fibroblasts. The alpha 2C-AR may couple preferentially to PT-sensitive G-proteins (Gi1, Go1,2) not expressed in NIH-3T3 fibroblasts and thereby elicit different cellular responses.


Subject(s)
Cyclic AMP/metabolism , GTP-Binding Proteins/metabolism , Receptors, Adrenergic, alpha/metabolism , Signal Transduction , 3T3 Cells , Adrenergic alpha-Agonists/metabolism , Animals , Brimonidine Tartrate , Cell Membrane/metabolism , Colforsin/pharmacology , Epinephrine/pharmacology , Guanylyl Imidodiphosphate/pharmacology , Kinetics , Mice , Pertussis Toxin , Quinoxalines/metabolism , RNA, Messenger/isolation & purification , RNA, Messenger/metabolism , Receptors, Adrenergic, alpha/drug effects , Receptors, Adrenergic, alpha/genetics , Transfection , Virulence Factors, Bordetella/pharmacology , Yohimbine/metabolism
20.
J Biol Chem ; 267(14): 9852-7, 1992 May 15.
Article in English | MEDLINE | ID: mdl-1349607

ABSTRACT

Cell to cell communication by many hormones and neurotransmitters involves three major entities: receptor (R), G-protein (G), and effector molecule (E). Plasticity in this system is conferred by the existence of each entity as isoforms or closely related subtypes that are expressed in a tissue-specific and developmentally regulated manner. Factors that determine signal specificity in this system are poorly understood. Such factors include the relative affinity and stoichiometry of R-G or G-E and the possible colocalization of R-G-E in cellular microdomains. Utilizing the alpha 2-adrenergic receptor (alpha 2-AR) system as a representative subfamily of this class of signal transducers, we determined the relative importance of these factors. By analysis of R-G coupling in mammalian cells cotransfected with alpha 2-AR genes and G alpha cDNA, we demonstrate preferential coupling between an alpha 2-AR subtype and Go. Our data implicate R-G affinity as an important determinant of signal transduction specificity and indicate that a critical level of Go alpha is required for coupling. This report indicates the utility of R-G cotransfection in mammalian cells as a "natural environment model" to characterize events occurring at the R-G and G-E interface.


Subject(s)
GTP-Binding Proteins/metabolism , Receptors, Adrenergic, alpha/metabolism , Signal Transduction , 3T3 Cells , Adrenergic alpha-Agonists/metabolism , Animals , Brimonidine Tartrate , Cell Membrane/metabolism , Epinephrine/pharmacology , GTP-Binding Proteins/genetics , Guanylyl Imidodiphosphate/pharmacology , Immunoblotting , Kinetics , Membrane Proteins/isolation & purification , Membrane Proteins/metabolism , Mice , Plasmids , Protein Binding , Quinoxalines/metabolism , Receptors, Adrenergic, alpha/drug effects , Receptors, Adrenergic, alpha/genetics , Transfection , Yohimbine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...